|
CMS to Deny Incomplete Claims on Discarded Drugs Starting in October
The week of Oct. 2, the Centers for Medicare & Medicaid Services (CMS) will kick back certain claims involving discarded or unused drugs if practices fail to implement a new billing and coding policy the payer has been phasing in since the beginning of the year. Read more
Last Chance CME
Physicians have until Oct. 14 to access a webinar on evaluation and management coding changes that began in 2021. Watch the webinar to improve level-of-service selection skills, learn proper documentation, and more. Get the course
Payer Use of AI Sparks Concerns
Among other products, payers are using artificial intelligence (AI) to process prior authorization requests with results that, on the one hand, can deliver near-instantaneous approvals, and on the other hand, employ algorithms that appear to systematically deny coverage. Worried about how payers’ AI products affect their patients and their practices, physicians are seeking transparency. Read the Texas Medicine story
Novavax's COVID-19 Vaccine Gets FDA Authorization
The Food and Drug Administration (FDA) granted emergency use authorization to Novavax’s COVID-19 vaccine on Oct. 3, bringing the number of immunizations effective against the current circulating strain up to three. Novavax’s vaccine, a more traditional protein-based shot that differs from the mRNA vaccines that have become commonplace, has been authorized for people 12 years of age and older. Previously vaccinated people are eligible for one dose while those who haven’t been immunized yet are eligible for two. Read more
|
